Published in Int J Mol Cell Med on August 10, 2016
The DNA sequence of human chromosome 21. Nature (2000) 10.66
Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet (2001) 5.64
The somatic chromosomes in mongolism. Lancet (1959) 3.61
Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet (2004) 3.58
Health and disease in adults with Down syndrome. Tidsskr Nor Laegeforen (2013) 3.46
The epidemiology of mental retardation: challenges and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev (2002) 3.26
The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome. Genet Med (2009) 2.83
Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn (2012) 2.79
Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol (2012) 2.39
Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome. Nat Neurosci (2010) 2.08
First-trimester sonographic screening for Down syndrome. Obstet Gynecol (2003) 2.05
Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings. Am J Obstet Gynecol (2015) 2.05
Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol (2015) 1.96
An angel with Down syndrome in a sixteenth century Flemish Nativity painting. Am J Med Genet A (2003) 1.95
Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J Hum Genet (2008) 1.90
Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn (2012) 1.88
Translating dosage compensation to trisomy 21. Nature (2013) 1.75
ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med (2013) 1.73
New insights into human nondisjunction of chromosome 21 in oocytes. PLoS Genet (2008) 1.68
Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur J Hum Genet (2012) 1.51
Assessment of the value of reporting partial screening results in prenatal screening for Down syndrome. Prenat Diagn (2001) 1.45
Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects. Hum Genet (2008) 1.22
Down syndrome: genetic recombination and the origin of the extra chromosome 21. Clin Genet (2000) 1.22
Human chromosome 21: genome mapping and exploration, circa 1993. Trends Genet (1993) 1.21
Genetic and other diseases in the pottery of Tumaco-La Tolita culture in Colombia-Ecuador. Clin Genet (2006) 1.13
Maternal cfDNA screening for Down syndrome--a cost sensitivity analysis. Prenat Diagn (2013) 1.08
Upregulation of three Drosophila homologs of human chromosome 21 genes alters synaptic function: implications for Down syndrome. Proc Natl Acad Sci U S A (2009) 1.08
Molecular basis of pharmacotherapies for cognition in Down syndrome. Trends Pharmacol Sci (2009) 1.04
Mechanistic insights into chromosome-wide silencing in X inactivation. Hum Genet (2011) 1.00
Cell-free DNA Analysis for Noninvasive Examination of Trisomy. N Engl J Med (2015) 0.99
Current estimate of Down Syndrome population prevalence in the United States. J Pediatr (2013) 0.98
The incidence patterns of Down syndrome in Qatar. Clin Genet (2006) 0.96
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome. Nat Rev Neurosci (2015) 0.96
Fetal nose bone length: a marker for Down syndrome in the second trimester. J Ultrasound Med (2002) 0.95
Incidence of Down syndrome in Dubai, UAE. Med Princ Pract (2007) 0.93
Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open (2016) 0.93
Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn (2003) 0.92
Fetal pyelectasis: a possible association with Down syndrome. Obstet Gynecol (1990) 0.90
Prenatal Diagnosis Innovation: Genome Sequencing of Maternal Plasma. Annu Rev Med (2015) 0.88
Sonographic markers for early diagnosis of fetal malformations. World J Radiol (2013) 0.86
The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure. Prenat Diagn (2015) 0.82
Soft tissue nuchal fold in the second-trimester fetus: standards for normal measurements compared with those in Down syndrome. Am J Obstet Gynecol (1987) 0.82
A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome. Am J Obstet Gynecol (1985) 0.81
Reliability of fetal nasal bone length measurement at 11-14 weeks of gestation. BMC Pregnancy Childbirth (2013) 0.79
Fetal pyelectasis and Down syndrome: is genetic amniocentesis warranted? Obstet Gynecol (1992) 0.78
Nuchal translucency distributions for different chromosomal anomalies in a large unselected population cohort. Prenat Diagn (2015) 0.78
Cell-free DNA Analysis for Noninvasive Examination of Trisomy. N Engl J Med (2015) 0.78
Can sonographers reliably identify anatomic features associated with Down syndrome in fetuses? Radiology (1989) 0.78
Risk of Major Cardiovascular Events in People with Down Syndrome. PLoS One (2015) 0.78
Cytogenetic profile in 1,921 cases of trisomy 21 syndrome. Arch Med Res (2015) 0.77
"Down syndrome: an insight of the disease". J Biomed Sci (2015) 0.77
Single Nucleotide Polymorphism-Based Analysis of Cell-Free Fetal DNA in 3000 Cases from Germany and Austria. Ultrasound Int Open (2015) 0.76
Molecule of the month: miRNA and Down's syndrome. Bioinformation (2013) 0.76
Imaging findings in Down syndrome. Pediatr Radiol (2014) 0.76
Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening. Clin Perinatol (2014) 0.76
First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-β human chorionic gonadotrophin, placental growth factor, and α-fetoprotein. Prenat Diagn (2015) 0.76
Cell free fetal DNA testing in maternal blood of Romanian pregnant women. Iran J Reprod Med (2015) 0.76
Editorial: The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective. Curr Alzheimer Res (2016) 0.76
Current controversies in prenatal diagnosis 3: is there still a value in a nuchal translucency screening ultrasound in conjunction with maternal plasma non-invasive cell-free DNA testing? Prenat Diagn (2015) 0.76